Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Telecom Plus guides to further profit growth after record results

(Sharecast News) - Telecom Plus reported record profits in line with market expectations in the 12 months to 31 March despite a slip in revenues, and pointed to further growth in the year ahead. The company, which provides subscription-style essential household services in the UK, said the 20% drop in the Ofgem energy price cap during the year, which averaged £1,700, led to a fall in revenues to £1.84bn from £2.04bn.

However, adjusted pre-tax profit totalled £126.3m, up 8.1% over the previous year, with guidance of £132m-138m given for FY26.

Customer numbers increased by 15% over the year to 1.16m, including 25,000 fixed-line/broadband customers transferred from TalkTalk as part of a cross-selling transaction. Excluding the TalkTalk customers, organic customer growth came in at 12.6%, in line with guidance.

Meanwhile, service numbers increased 8.4% to 3.39m, though this rate of growth should accelerate going forwards following the recent relaunch of insurance products, Telecom Plus said.

The company proposed a final dividend of 57p, up from 47p previously, taking the full-year payout to 94p, up 13% on last year.

"Our innovative multiservice platform, together with our unique word of mouth route to market, has enabled us to deliver another set of record results," said chief executive Stuart Burnett.

"Now into our fourth consecutive year of delivering double digit percentage customer growth, we are making rapid progress towards our medium term target of supplying subscription-style essential household services to two million customers and beyond."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Nationwide fined £44m for financial crime control failures
(Sharecast News) - Nationwide has been slapped with a £44m fine by the UK's financial regulator for financial crime prevention failures from October 2016 to July 2021.
SolGold recommends revised £842m from Jiangxi Copper
(Sharecast News) - Copper-gold miner SolGold has recommended shareholders vote in favour of a revised £842m cash offer from Chinese copper giant and Jiangxi Copper Company, which has already received the support from other major shareholders.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.